15 research outputs found
Selection of extreme phenotypes: the role of clinical observation in translational research
Systematic collection of phenotypes and their correlation with molecular data has been proposed as a useful method to advance in the study of disease. Although some databases for animal species are being developed, progress in humans is slow, probably due to the multifactorial origin of many human diseases and to the intricacy of accurately classifying phenotypes, among other factors. An alternative approach has been to identify and to study individuals or families with very characteristic, clinically relevant phenotypes. This strategy has shown increased efficiency to identify the molecular features underlying such phenotypes. While on most occasions the subjects selected for these studies presented harmful phenotypes, a few studies have been performed in individuals with very favourable phenotypes. The consistent results achieved suggest that it seems logical to further develop this strategy as a methodology to study human disease, including cancer. The identification and the study with high-throughput techniques of individuals showing a markedly decreased risk of developing cancer or of cancer patients presenting either an unusually favourable prognosis or striking responses following a specific treatment, might be promising ways to maximize the yield of this approach and to reveal the molecular causes that explain those phenotypes and thus highlight useful therapeutic targets. This manuscript reviews the current status of selection of extreme phenotypes in cancer research and provides directions for future development of this methodology
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM)
Cancer treatment involves the participation of multiple medical specialties and, as our knowledge of the disease increases, this fact becomes even more apparent. The degree of multidisciplinarity is determined by several factors, which include the severity and type of disease, the increasing diversity in the available pharmacological and non-pharmacological therapies, and the range of specialists involved in cancer therapy, such as medical oncologists, radiotherapists, gynecologists, gastroenterologists, urologists, surgeons, and pneumologists, among others. Across Europe, the situation of cancer care can be variable due to the diversity of health systems, differences in drug reimbursement, and the degree of establishment of Medical Oncology as a medical specialty in the European Union states
Estudo dos cortes da carcaça de cordeiros Santa Inês puros e cruzas Santa Inês com Texel, Ile de France e Bergamácia
Supporting Information ß2-adrenergic stimulation potentiates spontaneous calcium release by increasing signal mass and co-activation of ryanodine receptor clusters
Peer reviewe
Guia de lípids i risc cardiovascular
Colesterol; Risc coronari; HipercolesterolèmiaCholesterol; Coronary risk; HypercholesterolemiaColesterol; Riesgo coronario; HipercolesterolemiaL’objectiu general d’aquesta guia és disposar d’unes recomanacions basades
en l’evidència científica sobre el maneig dels lípids segons el risc cardiovascular
(RCV). Aquesta guia engloba tot el procés assistencial i inclou els objectius
comuns per tal d’augmentar la qualitat assistencial i disminuir la variabilitat
assistencial en l’abordatge dels lípids i l’RCV
Hipercolesterolèmia: guies de pràctica clínica
Hipercolesterolèmia; Recomanacions; DiagnòsticHipercolesterolemia; Recomendaciones; DiagnósticoHypercholesterolemia; Recommendations; DiagnosisGuia breu d'abordatge de la hipercolesterolèmia, que aporta una revisió acurada del coneixement científic actualment disponible sobre aquest tema i la seva traducció en recomanacions per a la pràctica diària
Hipercolesterolèmia: guies de pràctica clínica
Hipercolesterolèmia; Recomanacions; DiagnòsticHipercolesterolemia; Recomendaciones; DiagnósticoHypercholesterolemia; Recommendations; DiagnosisGuia breu d'abordatge de la hipercolesterolèmia, que aporta una revisió acurada del coneixement científic actualment disponible sobre aquest tema i la seva traducció en recomanacions per a la pràctica diària
An easy, rapid and objective mathematical method to identify fatty acid synthase (oncogenic antigen-519) modulators with potential anticancer value
Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trial
BACKGROUND & AIMS: To assess the possible association between a validated Dietary Inflammatory Index (DII) and specific dietary components with suitable non-invasive markers of liver status in overweight and obese subjects within the PREDIMED study. METHODS: A cross-sectional study encompassing 794 randomized overweight and obese participants (mean ± SD age: 67.0 ± 5.0 y, 55% females) from the PREDIMED (PREvención con DIeta MEDiterránea) trial was conducted. DII is a validated tool evaluating the effect of diet on six inflammatory biomarkers (IL-1b, IL-4, IL-6, IL-10, TNF-α and C-reactive protein). Furthermore, a validated 137-item food-frequency-questionnaire was used to obtain the information about the food intake. In addition, anthropometric measurements and several non-invasive markers of liver status were assessed and the Fatty Liver Index (FLI) score was calculated. RESULTS: A higher DII and lower adherence to Mediterranean diet (MeDiet) were associated with a higher degree of liver damage (FLI > 60) in obese as compared to overweight participants. Furthermore, the DII score was positively associated with relevant non-invasive liver markers (ALT, AST, GGT and FLI) and directly affected FLI values. Interestingly, a positive correlation was observed between liver damage (>50th percentile FLI) and nutrients and foods linked to a pro-inflammatory dietary pattern. CONCLUSIONS: This study reinforced the concept that obesity is associated with liver damage and revealed that the consumption of a pro-inflammatory dietary pattern might contribute to obesity and fatty liver disease features. These data suggest that a well-designed precision diet including putative anti-inflammatory components could specifically prevent and ameliorate non-alcoholic fatty liver manifestations in addition to obesity